Syracuse WUN Town Hall Recap

Wake Up Narcolepsy Announces AASM Foundation 2025 Grant Partnership & 2024 Grant Update

Wake Up Narcolepsy Announces Tammy Anderson as Executive Director and Honors Founder Monica Gow’s Inspiring 16 Year Legacy

Wake Up Narcolepsy’s 2024 End of Year Giving Campaign Needs Your Support!

Register now for WUN’s 2025 National Summit

Wake Up Narcolepsy Representatives Attend 2024 Sleep Advocacy Forum in Washington D.C.

Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Family Weekend 2024 Recap

Join Us for November’s Brown Bag Webinar – Unraveling the Mysteries of Dreams & Nightmares in Narcolepsy

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) ExtendedRelease Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy